Hospital readmission and mortality in chinese patients with heart failure stratified by ejection fraction levels after treatment with sacubitril/valsartan

被引：0
|
作者：
Ye, X. [1 ]
Chan, E. S. Y. [2 ]
Man, K. K. C. [2 ]
Wong, C. K. [3 ]
Tse, H. F. [3 ]
Chan, E. W. [1 ]
机构：
[1] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China
[2] UCL, Sch Pharm, London, England
[3] Univ Hong Kong, Sch Clin Med, LKS Fac Med, Dept Med, Hong Kong, Peoples R China
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [31] Effect of Body Mass Index on Mortality In Patients with Heart Failure with Reduced Ejection Fraction Receiving Sacubitril/Valsartan
    Kido, Kazuhiko
    Bianco, Christopher
    Caccamo, Marco
    Sokos, George
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S129 - S129
  • [32] CHANGES IN EJECTION FRACTION AND GLOBAL LONGITUDINAL STRAIN ASSESSMENT IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION AFTER THERAPY WITH SACUBITRIL/VALSARTAN
    Pandey, Amitabh C.
    Pelter, Megan
    Montgomery, Paul
    Kuo, Ruth
    Shen, Christine
    Sidhu, Rajbir
    Lerner, David
    Billick, Kristin
    Hay, Brooke
    Loveday, Alyssa
    Duckett, Ashley
    Suresh, Siddharth
    Srivastava, Ajay
    Rubenson, David
    Heywood, J. Thomas
    Mohan, Rajeev
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 832 - 832
  • [33] Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2023, 20 : 515 - 515
  • [34] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [35] EFFICACY OF SACUBITRIL/VALSARTAN INMAINTENANCE HEMODIALYSIS PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Fu, Sha
    Wang, Xiaohong
    Song, Qirong
    Chen, Junzhe
    Tang, Ying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I161 - I162
  • [36] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [37] Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV)
    Kong, M. G.
    Suh, J.
    Moon, I. K.
    Lee, K. Y.
    Jang, H. J.
    Kim, J. S.
    Choi, I. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 967 - 967
  • [38] TOLERABILITY OF SACUBITRIL-VALSARTAN IN PATIENTS WITH CANCER AND HEART FAILURE WITH REDUCED EJECTION FRACTION
    Yarrabothula, Akshitha R.
    Alsheikh-Kassim, Mohammad
    Amatullah, Atia
    Fossas, Jose
    Salman, Justin
    Seal, Zachary
    Lin, Heather
    Irizarry-Caro
    Wanna, Charles
    Miller, Chase
    Fatakdawala, Mariya
    Palaskas, Nicolas L.
    Deswal, Anita
    Koutroumpakis, Efstratios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2325 - 2325
  • [39] Clinical benefit of sacubitril-valsartan in patients with heart failure with reduced ejection fraction
    Spinoni, Enrico Guido
    Lio, Veronica
    Degiovanni, Anna
    Erbetta, Riccardo
    Marino, Paolo
    Patti, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N101 - N101
  • [40] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
12345